These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8922414)

  • 1. Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-L-cysteine.
    Henderson JT; Javaheri M; Kopko S; Roder JC
    J Neurosci; 1996 Dec; 16(23):7574-82. PubMed ID: 8922414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
    Iwamoto K; Yoshii Y; Ikeda K
    Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    J Neurol Sci; 1998 Sep; 160(1):9-15. PubMed ID: 9804111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease.
    Gonzalez Deniselle MC; Garay L; Gonzalez S; Guennoun R; Schumacher M; De Nicola AF
    Exp Neurol; 2005 Oct; 195(2):518-23. PubMed ID: 16095593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease.
    Ikeda K; Wong V; Holmlund TH; Greene T; Cedarbaum JM; Lindsay RM; Mitsumoto H
    Ann Neurol; 1995 Jan; 37(1):47-54. PubMed ID: 7818257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
    Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
    Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced branching and length of dendrites detected in cervical spinal cord motoneurons of Wobbler mouse, a model for inherited motoneuron disease.
    Ma WY; Vacca-Galloway LL
    J Comp Neurol; 1991 Sep; 311(2):210-22. PubMed ID: 1721631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation.
    Röderer P; Klatt L; John F; Theis V; Winklhofer KF; Theiss C; Matschke V
    Mol Neurobiol; 2018 Nov; 55(11):8414-8424. PubMed ID: 29549647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithinized superoxide dismutase retards wobbler mouse motoneuron disease.
    Ikeda K; Kinoshita M; Iwasaki Y; Tagaya N; Shiojima T
    Neuromuscul Disord; 1995 Sep; 5(5):383-90. PubMed ID: 7496172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
    Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
    Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the wobbler mouse, a model of motor neuron degeneration.
    Bastone A; Fumagalli E; Bigini P; Perini P; Bernardinello D; Cagnotto A; Mereghetti I; Curti D; Salmona M; Mennini T
    J Proteome Res; 2009 Nov; 8(11):5229-40. PubMed ID: 19764823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate transporters in the spinal cord of the wobbler mouse.
    Bigini P; Bastone A; Mennini T
    Neuroreport; 2001 Jul; 12(9):1815-20. PubMed ID: 11435904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Selective Glucocorticoid Receptor Modulator Cort 113176 Reduces Neurodegeneration and Neuroinflammation in Wobbler Mice Spinal Cord.
    Meyer M; Lara A; Hunt H; Belanoff J; de Kloet ER; Gonzalez Deniselle MC; De Nicola AF
    Neuroscience; 2018 Aug; 384():384-396. PubMed ID: 29890290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease.
    Gonzalez Deniselle MC; López-Costa JJ; Saavedra JP; Pietranera L; Gonzalez SL; Garay L; Guennoun R; Schumacher M; De Nicola AF
    Neurobiol Dis; 2002 Dec; 11(3):457-68. PubMed ID: 12586554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):207-12. PubMed ID: 11464954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse.
    Ikeda K; Iwasaki Y
    PLoS One; 2015; 10(10):e0140316. PubMed ID: 26469273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron.
    Mitsumoto H; Bradley WG
    Brain; 1982 Dec; 105 (Pt 4)():811-34. PubMed ID: 7139256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease.
    Hantaï D; Akaaboune M; Lagord C; Murawsky M; Houenou LJ; Festoff BW; Vaught JL; Rieger F; Blondet B
    J Neurol Sci; 1995 May; 129 Suppl():122-6. PubMed ID: 7595602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
    Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
    Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of a novel free radical scavenger, OPC-14117, on wobbler mouse motor neuron disease.
    Abe K; Morita S; Kikuchi T; Itoyama Y
    J Neurosci Res; 1997 Apr; 48(1):63-70. PubMed ID: 9086182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.